Related Experiment Videos
[Allogeneic heart-lung transplantation--present state and perspectives]
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
|May 15, 1986
Summary
Isolated heart transplantation offers a vital treatment for end-stage heart disease when other methods fail. Future combined heart-lung transplants may expand options for complex cardiac and pulmonary conditions.
Area of Science:
- Cardiology
- Thoracic Surgery
- Transplantation Medicine
Background:
- End-stage heart disease often presents limited treatment options.
- Conventional medical and surgical interventions may be insufficient for severe cases.
Purpose of the Study:
- To review the indications, techniques, immunosuppression protocols, and outcomes of isolated heart transplantation.
- To explore the potential of combined heart-lung transplantation for advanced cardiovascular and pulmonary diseases.
Main Methods:
- Literature review and analysis of existing data on heart transplantation.
- Survey of current practices in immunosuppression and surgical techniques.
Main Results:
- Isolated heart transplantation is a viable therapeutic option for patients with refractory heart failure.
- The procedure offers a chance for survival and improved quality of life.
Conclusions:
- Isolated heart transplantation is a crucial alternative for patients unresponsive to traditional treatments.
- Combined heart-lung transplantation holds promise for managing terminal heart disease with pulmonary hypertension or end-stage lung disease.